Core Insights - Digital Biotechnologies Inc., a new subsidiary of Adaptive Biotechnologies, has successfully raised funds through an initial closing of a Series A investment round [1] Company Overview - Digital Biotechnologies Inc. is based in Seattle and operates under the umbrella of Adaptive Biotechnologies, which is publicly traded and focuses on immune medicine [1] Financial Activity - The company has completed an initial closing of a Series A investment round, indicating a positive reception from investors and potential for future growth [1]